A Case of Recurred Hepatocellular Carcinoma Refractory to Doxorubicin After Liver Transplantation Showing Response to Herbal Medicine Product, Rhus verniciflua Stokes Extract
Authors:
Open Access
- 21 March 2010
- journal article
- research article
- Published by SAGE Publications in Integrative Cancer Therapies
- Vol. 9 (1) , 100-104
Abstract
There is no established protocol proven to be beneficial for treatment of hepatocellular carcinoma recurrence after liver transplantation. Only a few reports have shown direct treatment by surgery or ablation to be independent predictors of survival for localized recurrence. Moreover, the necessity of immunosuppression to prevent allograft rejection makes many physicians hesitate to administer systemic chemotherapy. This case report documents a case in which the administration of an herbal product, an extract of the lacquer tree, Rhus verniciflua Stokes, was associated with a decrease in the size of lung metastases in a patient with recurrent hepatocellular carcinoma after liver transplantation refractory to doxorubicin. This patient experienced prolonged survival compared with average survival times and little toxicity.Keywords
This publication has 20 references indexed in Scilit:
- Palliative chemotherapy for patients with recurrent hepatocellular carcinoma after liver transplantationJournal of Gastroenterology and Hepatology, 2009
- A phase II study of oxaliplatin in combination with doxorubicin as first-line systemic chemotherapy in patients with inoperable hepatocellular carcinomaCancer Chemotherapy and Pharmacology, 2008
- Sorafenib in Advanced Hepatocellular CarcinomaNew England Journal of Medicine, 2008
- Phase III Randomized Controlled Trial Comparing the Survival of Patients With Unresectable Hepatocellular Carcinoma Treated With Nolatrexed or DoxorubicinJournal of Clinical Oncology, 2007
- Outcome of Patients With Recurrent Hepatocellular Carcinoma in Liver TransplantationTransplantation Proceedings, 2006
- Systemic chemotherapy with doxorubicin, cisplatin and capecitabine for metastatic hepatocellular carcinomaBMC Cancer, 2006
- A Randomized Phase III Study of Doxorubicin Versus Cisplatin/Interferon α-2b/Doxorubicin/Fluorouracil (PIAF) Combination Chemotherapy for Unresectable Hepatocellular CarcinomaJNCI: Journal of the National Cancer Institute, 2005
- How should patients with hepatocellular carcinoma recurrence after liver transplantation be treated?Journal of Hepatology, 2005
- Liver Transplantation for Adult Patients with Hepatocellular Carcinoma in KoreaLiver Transplantation, 2005
- Recurrence of hepatocellular carcinoma after liver transplant: Patterns and prognosisLiver Transplantation, 2004